Replies to post #251662 on Biotech Values

[vinmantoo]

4) Somewhat unrelated, if it were such that Enanta's patent was upheld in court might that also serve to encourage a potential phase 3 trial collaboration?

Keep in mind that ENTA is suing PFE because they claim that Paxlovid violated one of ENTA's patents. ENTA's anti-Covid drug EDP-235 is not part of this patent dispute but is a different compound.